Evidence map›Paper›PMID 34054793›Full record

ReviewFrontiers in immunology2021

Identify. Quantify. Predict. Why Immunologists Should Widely Use Molecular Imaging for Coronavirus Disease 2019.

Freimut D Juengling, Antonio Maldonado, Frank Wuest, Thomas H Schindler

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. COVID-19 pneumonia detected by [BJR case reports · 2022
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Freimut D JuenglingMedical Faculty, University Bern, Bern, Switzerland.
Antonio MaldonadoDepartment of Nuclear Medicine and Molecular Imaging, Quironsalud Madrid University Hospital, Madrid, Spain.
Frank WuestDepartment of Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Thomas H SchindlerMallinckrodt Institute of Radiology, Division of Nuclear Medicine, Washington University School of Medicine, Saint Louis, MO, United States.
Hospital Universitario Quirónsalud Madrid · ESMallinckrodt (United States) · USUniversity of Alberta · CAUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular imaging using PET/CT or PET/MRI has evolved from an experimental imaging modality at its inception in 1972 to an integral component of diagnostic procedures in oncology, and, to lesser extent, in cardiology and neurology, by successfully offering

Indexed as

AnimalsCOVID-19Diagnostic Tests, RoutineHumansMagnetic Resonance ImagingMolecular ImagingPositron-Emission TomographyPredictive Value of TestsPrognosisRadioligand AssayRNA, ViralSARS-CoV-2RNA, ViralACE-2-receptorCOVID-19COX-2CXCR4cytokine stormmolecular imagingP2X7 (purino) receptorSARS-CoV-2

Identifiers

PMID34054793
PMCPMC8155634
OpenAlexW3162668697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.